These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18959234)

  • 1. [Recent advances in the detection of recombinant human erythropoiesis and its analogs in doping control].
    Yang X; Pang N; Liao Y; Liu H
    Se Pu; 2008 Jul; 26(4):413-6. PubMed ID: 18959234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances in the detection of human erythropoietin and human growth hormone doping].
    Guo L; Zhang Z; Tang J; Xie J
    Se Pu; 2008 Jul; 26(4):437-43. PubMed ID: 18959238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant erythropoietin and analogues: a challenge for doping control.
    Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
    Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmatory analysis of continuous erythropoietin receptor activator and erythropoietin analogues in equine plasma by LC-MS for doping control.
    Guan F; Uboh CE; Soma LR; Maylin G; Jiang Z; Chen J
    Anal Chem; 2010 Nov; 82(21):9074-81. PubMed ID: 20945883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analytical approach for detection of carbamylated erythropoietin for doping control purposes.
    Kaliszewski P; Siek P; Zalewska Z; Michalak D; Kwiatkowska D
    Drug Test Anal; 2020 Nov; 12(11-12):1599-1604. PubMed ID: 33119952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control.
    Delcourt V; Garcia P; Chabot B; Loup B; Remy P; Popot MA; Bailly-Chouriberry L
    Drug Test Anal; 2020 Jun; 12(6):763-770. PubMed ID: 31984676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of darbepoetin alfa in human plasma by liquid chromatography coupled to mass spectrometry for doping control.
    Guan F; Uboh CE; Soma LR; Birksz E; Chen J
    Int J Sports Med; 2009 Feb; 30(2):80-6. PubMed ID: 19177313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.
    Diamanti-Kandarakis E; Konstantinopoulos PA; Papailiou J; Kandarakis SA; Andreopoulos A; Sykiotis GP
    Sports Med; 2005; 35(10):831-40. PubMed ID: 16180943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
    Wilber RL
    Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures for monitoring recombinant erythropoietin and analogues in doping control.
    Segura J; Pascual JA; Gutiérrez-Gallego R
    Anal Bioanal Chem; 2007 Aug; 388(7):1521-9. PubMed ID: 17516052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis.
    Lasne F; Thioulouse J; Martin L; de Ceaurriz J
    Electrophoresis; 2007 Jun; 28(12):1875-81. PubMed ID: 17503402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
    Leuenberger N; Reichel C; Lasne F
    Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances and strategies in gene doping detection].
    He J; Liu Z; Liu J; Dou P; Chen HY
    Se Pu; 2008 Jul; 26(4):402-7. PubMed ID: 18959232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
    Reichel C
    Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
    [No Abstract]   [Full Text] [Related]  

  • 19. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
    Pitsiladis YP; Durussel J; Rabin O
    Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.